Company Overview of SyStemix, Inc.
SyStemix, Inc. was acquired by Novartis AG. In February 1997, SyStemix, Inc. completed a merger with Novartis Biotech Holding Corp., an indirect wholly owned subsidiary of Novartis, Inc., pursuant to which SyStemix became an indirect wholly owned subsidiary of Novartis. Previously, SyStemix, Inc. was engaged in the development of cellular and cell-based gene therapies for cancer, AIDS, and genetic diseases based on the use of isolated, expanded, and gene-modified hematopoietic stem cells.
3155 Porter Drive
Palo Alto, CA 94304
Key Executives for SyStemix, Inc.
SyStemix, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Cytograft Tissue Engineering, Inc.||United States|
|ArmaGen Technologies, Inc.||United States|
|KromaTiD, Inc.||United States|
|Forticell Bioscience, Inc.||United States|
|Diamond Animal Health, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact SyStemix, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.